
7th work meeting
Champéry, Switzerland
In the Valais Alps: gene editing in Parkinson's and heart disease, European health systems and co-morbidity, and the society's own future establishment.
- Dates
- 16–18 June 2017
- Venue
- Hotel National Resort & Spa, Champéry, Valais, Switzerland
- Convened by
- Dr. Marco Traub
Programme
What was discussed
- 01
European Innovation Partnership on Active and Healthy Ageing
- 02
Gene editing in Parkinson's and heart disease
- 03
European health care systems and co-morbidity
- 04
Paradigm change: shifting from patient centricity to society, and pharma as a holistic view
- 05
TESCT Society: future establishment
Recalling Prof. Dame Julia Polak, TESCT meeting 2006
“Regenerative medicine is an emerging field that approaches the repair or replacement of tissues and organs by incorporating the use of cells, genes or other biological building blocks along with bioengineered materials and technologies. Advances in stem cell biology, including the isolation and characterisation of embryonic and post-natal somatic stem cells, have made the prospect of tissue repair a realistic one.”
Speakers
Who spoke
Dr. Mary Baker, MBE
Management Board of the European Medicines Agency (EMEA); Chair of the Working Group on Parkinson's Disease
Marco Perduca
Former Senator in Italy; Associazione Luca Coscioni
Prof. Tomas J. Ekström
Department of Clinical Neuroscience, Karolinska Institutet, Sweden
Prof. Miomir Knezevic
National Institute of Biology, University of Ljubljana, Slovenia
Dr. Marisa Jaconi
University of Geneva, Switzerland
Dr. Colin Natali
The Royal London Hospital, Whitechapel, London
Dr. Jeya Prakash
Age Management Consultant, Harley Street, London
Dr. Srividya Seshadri
The Centre for Reproductive & Genetic Health, London
Dr. Alagappan Sivaram
Consultant Orthopaedic Spinal Surgeon, London
Dr. Marco Traub
Project Coordinator and CEO, TESCT, Berne and London




